Hong Liu

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Xiaobo Yang, Yu Yuan, Jiqian Xu et al. · The Lancet Respiratory Medicine · 2020 · 10.7K citations · Full text

Medicine, Infectious Diseases, Internal Medicine +14

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Zhenming Jin, Xiaoyu Du, Yechun Xu et al. · Nature · 2020 · 4.5K citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +10

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease

Wenhao Dai, Bing Zhang, Xia-Ming Jiang et al. · Science · 2020 · 1.6K citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Recent advances in the trifluoromethylation methodology and new CF3-containing drugs

Wei Zhu, Jiang Wang, Shuni Wang et al. · Journal of Fluorine Chemistry · 2014 · 488 citations

Pharmacy, Chemistry, Medicinal Chemistry +6

Development of Cell-Active <i>N</i>⁶-Methyladenosine RNA Demethylase FTO Inhibitor

Baoen Chen, Fei Ye, Lu Yu et al. · Journal of the American Chemical Society · 2012 · 447 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +15